New Delhi, Dec 22 (PTI) Zydus Lifesciences on Friday said the US health regulator has issued six observations after inspecting its active pharmaceutical ingredient (API) site in Ahmedabad, Gujarat.

The US Food and Drug Administration (USFDA) conducted the inspection from December 14 to December 22, 2023.

Also Read | AAI Recruitment 2023: Vacancies Notified For 119 Junior and Senior Assistant Posts, Know How to Apply at aai.aero.

The inspection closed with six observations, Zydus Lifesciences said in a regulatory filing.

There were no data integrity related observations, it added.

Also Read | APPSC Recruitment 2023: Vacancies Notified for 897 Posts of Group 2 Services, Apply Online at psc.ap.gov.in.

Besides, there are no repeat observations from the previous inspection, it noted.

There are four drug master files (DMFs) from the site under approval with the USFDA, the drugmaker said.

The company will closely work with the USFDA to address the observations, it added.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)